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ORIGINAL ARTICLE

Differential Detection and Distribution of Microglial and
Hematogenous Macrophage Populations in the Injured
Spinal Cord of lys-EGFP-ki Transgenic Mice
Leah A. Mawhinney, MSc, MD, Sakina G. Thawer, BSc, MSc, Wei-Yang Lu, PhD, Nico van Rooijen, PhD,
Lynne C. Weaver, DVM, PhD, Arthur Brown, PhD, and Gregory A. Dekaban, PhD

The acute inﬂammatory response that follows spinal cord injury
(SCI) contributes to secondary injury that results in the expansion
of the lesion and further loss of neurologic function. A cascade of
receptor-mediated signaling events after SCI leads to activation of
innate immune responses including the migration of microglia and
active recruitment of circulating leukocytes. Because conventional
techniques do not always distinguish macrophages derived from
CNS-resident microglia from blood-derived monocytes, the role that
each macrophage type performs cannot be assessed unambiguously
in these processes. We demonstrate that, in the normal and spinal
cordYinjured lys-EGFP-ki transgenic mouse, enhanced green ﬂuorescent protein (EGFP) is expressed only in mature hematopoietic
granulomyelomonocytic cells and not in microglia. This allowed us
to assess the temporal and spatial relationships between microgliaderived and hematogenous macrophages as well as neutrophils during a period of 6 weeks after clip compression SCI. Within the lesion,
EGFP-positive monocyteYderived macrophages were found at the
epicenter surrounded by EGFP-negativeYactivated microglia and
microglia-derived macrophages. Neutrophils were not present when
EGFP-positive monocyteYderived macrophages were depleted, indicating that neutrophil persistence in the lesion depended on the
presence of these monocytes. Thus, these 2 distinct macrophage
populations can be independently identiﬁed and tracked, thereby
allowing their roles in acute and chronic stages of SCI-associated
inﬂammation to be deﬁned.
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INTRODUCTION
The acute inﬂammatory response that follows mechanical injury to the spinal cord is a major contributor to the
secondary injury response and results in expansion of the lesion and further loss of neurologic function. The roles that
different inﬂammatory cells play in spinal cord injury (SCI)
remain unclear. Many studies examining ways to block or reduce the acute inﬂammatory responses to SCI have found that
these responses adversely affect neurologic recovery (1Y9).
However, inﬂammation is a critical part of the normal wound
healing process, and the acute inﬂammatory response to SCI
may also promote recovery (7Y13). These seemingly contradictory ﬁndings demonstrate that the role of inﬂammation and,
in particular, the phenotype and functional subsets of the responding immune cells need to be deﬁned further, as do their
temporal appearance and spatial distribution within the lesion.
Without this detailed understanding, effective clinical immunotherapies for SCI cannot be readily developed.
Spinal cord injury results in an inﬂammatory response
that is initiated by the release of proinﬂammatory mediators
from CNS cells resident in or adjacent to the lesion (1, 7, 9).
These mediators lead to a sequentially orchestrated activation
and migration of microglia toward the lesion and active recruitment of circulating leukocytes to the injury (1, 14). Once
in the injured spinal cord, identiﬁcation and tracking of each
type of inﬂammatory cell can be difﬁcult. Whereas neutrophils
are easily distinguished from microglia, macrophages derived
from microglia (mM?) and those derived from hematogenous
monocytes (hM?) are not readily discriminated owing to their
morphological and phenotypic similarities (15Y19). Hence,
within the spinal lesion, discerning the spatial distribution and
functional roles of these macrophages of different origins becomes a signiﬁcant challenge (3, 16, 18, 20).
The inability to distinguish between hM? and mM?
after SCI has limited progress in our understanding of their
cooperative and antagonistic relationship during wound healing and of temporal variations in that relationship. Previous
studies distinguishing mM? and hM? populations used bone
marrow chimeric rats or mice (16, 21Y23), whereas other studies used methods to deplete monocytes selectively (3). These
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MATERIALS AND METHODS
Animals
All protocols for this study were approved by the University of Western Ontario Animal Use Subcommittee and
conform to the Canadian Council on Animal Care guidelines.
The original lys-EGFP-ki transgenic mice were provided by
Dr Thomas Graf (28), from the Albert Einstein College of
Medicine (Bronx, NY), and homozygous mice were bred subsequently in the mouse barrier facility at the Robarts Research
Institute. Wild-type C57BL/6 mice were obtained from Charles
River Laboratories, Wilmington, MA.

Acute Spinal Cord Compression Injury
Mice (20Y26 g), 8 to 14 weeks old, underwent experimental clip compression injury at thoracic spinal segment 5
(T5), as previously described (33). Spinal cord injury was performed using a modiﬁed aneurysm clip (8 g force) (31). After
60 seconds of compression, the clip was removed, and the
surgical area was closed in layers. The force applied to the spinal cord produced a severe SCI and resulted in immediate
paraplegia. Postoperatively, the mice with SCI were treated as
previously described for rat studies with respect to hydration,

analgesia, and antibiotic therapy (34). Their bladders were emptied by manual compression twice daily for the ﬁrst 2 weeks
after SCI and then as needed.

Clodronic Acid Liposome Treatment
Premade clodronic acid liposomes (Clodronate Liposomes Foundation, Amsterdam, The Netherlands; http://www.
clodronateliposomes.org) were administered 24 hours before
surgical SCI to deplete macrophages from the blood, bone
marrow, spleen, liver, peritoneum, and most lymph nodes. For
each treatment, 100 Kl/10 g body weight was administered
intravenously (i.v.) and 50 Kl/10 g intraperitoneally (i.p.). Subsequently, treatments were administered every fourth day for
the duration of the experimental period. Enhanced green ﬂuorescent proteinYpositive leukocytes began to reappear in the
blood at this time in signiﬁcant numbers (data not shown),
consistent with previous literature reports (35). Depletion was
veriﬁed using ﬂow cytometry to assess the peripheral blood
leukocytes and splenocytes at the appropriate time points.
Mice with depletion greater than 85% to 90% were used.

PKH Liposome Staining
Control phosphate-buffered saline (PBS)Ycontaining liposomes were stained using a PKH26 red ﬂuorescent cell
linker kit (Sigma, St Louis, MO) to label the membrane portion of the liposomes. Brieﬂy, the staining procedure was as
follows: liposomes were washed with PBS (Gibco Invitrogen
Corp, Burlington, Canada) and subjected to ultracentrifugation, and the pellet was resuspended in diluent C provided by
the manufacturer. The staining solution, PKH dye in diluent
C, was quickly added to the liposomes and incubated for
5 minutes. The staining reaction was stopped with PBS containing 1% bovine serum albumin (BSA; Roche Diagnostics,
Basel, Switzerland). The sample was diluted with PBS, centrifuged as previously mentioned, and then washed with PBS.
The ﬁnal pellet was resuspended in PBS and stored at 4-C in
the dark. Visual ﬂuorescent microscopic examination veriﬁed
that all liposomes were stained with PKH26. For each animal,
100 Kl/10 g of the PKH-stained liposomes was administered
i.v. and 50 Kl/10 g i.p. either once at 24 hours before SCI or
twice at 24 hours before SCI and 3 days after SCI.

Tissue Preparation
Transcardiac perfusions were performed 1, 3, 4, 7, 14
and 42 days after SCI. All mice were deeply anesthetized with
an i.p. injection of ketamine/xylazine and perfused with oxygenated tissue culture medium (pH 7.4, Dulbecco modiﬁed
Eagle medium; Gibco), followed by 4% paraformaldehyde ﬁxative in 0.1 mol/L phosphate buffer (pH 7.4), both at room
temperature. The thoracic region of the spinal cords containing
the injury from spinal segments T3 to T6 was removed and
ﬁxed overnight at 4-C in 4% formaldehyde. The spinal cords
were cryoprotected in increasing concentrations of sucrose in
PBS (10%, 20%, and 30%) at 4-C. The spinal cord segments
were embedded with Tragacanth tissue gum (Sigma-Aldrich
Canada Ltd., Oakville, Canada) made with 30% sucrose or OCT
compound (Sakura Finetek, Inc, Torrance, CA); 16- to 20-Kmthick cross sections were cut on a cryostat (Leica CM3050 S;
Leica Microsystems Inc., Markham, Canada). Four sets of
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methods require alteration of the leukocyte populations of the
animals before SCI that lead to potential difﬁculties in data
interpretation, however (24, 25). An alternative method for
distinguishing microglia and mM? from monocytes and hM?
would be advantageous.
Examination of the literature suggested to us that lysozyme M might serve as useful marker to differentiate microglia and hematogenous macrophages (17, 26, 27). This study
characterizes the cellular inﬂammatory events associated with
SCI in the lysozyme MYEGFP-knock in (lys-EGFP-ki) transgenic mouse, a model that we propose for discriminating microglia and mM? from monocytes and hM? in SCI. In these
transgenic mice, the EGFP coding sequence replaces that of
lysozyme M and is regulated by the native lysozyme M promoter, which drives the expression of EGFP speciﬁcally in
mature myelomonocytic cells, including neutrophils, monocytes, and macrophages (28). These lys-EGFP-ki mice exhibit
normal developmental, behavioral, reproductive, and most immunologic characteristics but are more susceptible to certain
bacterial infections (28, 29). We previously found that microglia did not express EGFP in the brains of lys-EGFP-ki
mice with experimental autoimmune encephalomyelitis (30).
We therefore designed a study to determine whether microglia
and mM? could be distinguished from hM? in a mouse model
of SCI. We used a clip compression model because spinal
cord compression is a very common feature of human SCI (31).
Unlike the more commonly studied contusion mouse models
of SCI, clip compression involves an ischemia-reperfusion
component of the injury that likely generates a more intense
inﬂammatory response, thereby mimicking a signiﬁcant sector
of the human SCI population (31, 32). We report that EGFP,
under the control of the lysozyme M promoter, permits microglia and mM? to be distinguished temporally and spatially
from neutrophils, monocytes, and hM? after SCI.

Macrophage Response to Spinal Cord Injury in Mice

Mawhinney et al

alternate sections were mounted onto gel-coated slides and
allowed to dry for 24 hours.

Immunoﬂuorescence Microscopy

Quantiﬁcation of EGFP-Positive and
Ly6/GYPositive Cells
To quantify the labeled cells at the injury site, sections
from the injured spinal cord were viewed in a blinded fashion
using a Bio-Rad Radiance 2000 MP laser scanning 2-photon
confocal microscope (Bio-Rad Laboratories, Hertfordshire,
UK). Digital images of cross-sectional slices of the spinal cord
were acquired using a 10 objective and Laser-Sharp software (Bio-Rad). Eleven sections were quantiﬁed from each
injured cord. These sections were sampled evenly across the
T2YT5 region starting at the section in the middle of the
lesion. Five sections spaced 160 Km apart were sampled from
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the epicenter of the lesion to spinal segment T3 (rostral) and
from the epicenter to spinal segment T5 (caudal). Ly6/G (visualized by Rhodamine Red) and EGFP expressions were quantiﬁed separately from the same double-stained sections using
quantitative digital morphometry and ImagePro software version 4.5.1.22 (Media Cybernetics, Inc, Silver Springs, MD),
as previously described (34). Data are presented as the ratio
of the total immunoreactive area to the entire area of the spinal cord section assessed (designated as the area of interest)
and represent the relative amount of either Ly6/G+ or EGFP+
cells present in the spinal cord section.
Digital images were taken at 10, 20, 40, and 60
magniﬁcations using either a Bio-Rad Radiance 2000 MP
laser scanning confocal microscope or the Zeiss LSM 510
META-NLO. Images obtained on the Bio-Rad microscope were
processed using Laser-Sharp software (Bio-Rad). Alternatively, images were obtained with the Zeiss LSM 510 METANLO microscope and processed by Zeiss LSM 510 imaging
software version 3.0 (Carl Zeiss GmbH, Oberkochen, Germany).
Z-stack pictures were taken sequentially every 1.5 Km through
the entire tissue section. In addition, some digital images
were obtained with an Olympus IX50 epiﬂuorescence microscope and 3CCD Color Digital Video Camera (Olympus
Canada Inc., Markham, Canada) using ImagePro 5.1 software
and processed using Adobe Photoshop 5.02.

Biochemical Assays
At 24 hours, 72 hours, 1 week, or 2 weeks after injury,
mice were anesthetized and perfused with cold 0.9% NaCl.
A 0.5-cm-segment of spinal cord centered on the lesion site
was removed for analyses. Myeloperoxidase activity was determined as previously described (37). Free radicalYinduced
lipid peroxidation and enzymatic lipid peroxidation, a byproduct of arachidonic acid metabolism, was detected by a thiobarbituric acidYreactive substances assay that measures the
relative levels of malondialdehyde (MDA) and other aldehydes as previously described (37).

Production of Bone Marrow Chimeric Mice
Bone marrow was prepared from male C57BL/6 and
lys-EGFP-ki donor animals that were 8 to 10 weeks old (20Y
30 g), as described (38). After preparation, bone marrow cells
were suspended in PBS plus 3% fetal calf serum to a ﬁnal
concentration of 2.5  107 cells/mL. Female C57BL/6 and
lys-EGFP-ki recipients (20Y30 g) were sublethally irradiated
with 899 rad for 8 minutes in a small animal F-cell irradiation
chamber. The bone marrow cell suspension was transplanted
into the appropriate recipient 6 hours after irradiation by injecting 5 106 whole bone marrow cells into the tail vein.
Bone marrowYtransplanted mice were allowed to recover for
6 weeks before being subjected to SCI.

Peripheral Blood Preparation for Flow
Cytometry
Mice were deeply anesthetized with isoﬂurane. Blood
samples were obtained by intracardiac injection of heparin before cardiac puncture. Red blood cells were lysed by ACK
Ó 2012 American Association of Neuropathologists, Inc.

Copyright © 2012 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited.

Downloaded from https://academic.oup.com/jnen/article/71/3/180/2917370 by guest on 08 August 2022

A double-staining procedure was performed using detergent (quenching EGFP ﬂuorescence) permitting EGFP expression to be assessed quantitatively in sections costained for
Ly6/G (granulocytes) or F4/80 (monocyte/M?) or with
tomato lectin (TL; blood vessels and M?). Tissue sections
were blocked with 10% normal horse serum (Invitrogen) and
10% normal mouse serum (Jackson ImmunoResearch Laboratories, West Grove, PA) in TrisYphosphate-buffered saline
plus 0.3% Triton X-100 (TPBS-X, pH 7.4). The primary antibodies used were biotinylated anti-mouse Ly6/G (1:500;
eBioscience, San Diego, CA), F4/80 (Jackson ImmunoResearch
Laboratories), and Alexa Fluor 488Yconjugated rabbit antiGFP (1:1000; Molecular Probes, Burlington, Canada). Alternatively, a biotinylated anti-GFP antibody (1:1000; Santa Cruz
Biotechnology, Santa Cruz, CA), ampliﬁed with biotinylated
tyramide, as previously described (36), was used with the
Rhodamine Red ﬂuorochrome conjugated to streptavidin
(1:200; Jackson ImmunoResearch Laboratories). Anti-human
myeloperoxidase (MPO) antibody was used as previously
described (34). Biotinylated TL staining (Lycopersicon
esculentum, 20 Kg/mL; Vector Laboratories, Burlington,
Canada) was performed according to the manufacturer’s instructions with streptavidin Alexa Fluor 594 and then with
the Alexa Fluor 488 anti-GFP antibody, as described previously. All washes were performed in 1% normal horse serum
plus 1% normal mouse serum in either TPBS-X or TPBS,
unless otherwise indicated by the manufacturer. Alternatively, a method was developed for a detergent-free staining
procedure using biotinylated anti-mouse CD11b and antimouse Ly6/G to preserve EGFP ﬂuorescence. Sections were
blocked as described previously and then exogenous biotin
was blocked with an avidin/biotin blocking kit (Vector
Laboratories). The sections were then incubated for 3 days at
4-C with either biotinylated anti-CD11b (1:200) or biotinylated anti-Ly6/G (1:200) in TPBS, followed by washing
in the absence of detergent. Slides were stained with 4’,6diamidino-2-phenylindole (1:1000 in PBS) for 5 minutes,
washed with TPBS and ﬁnally rinsed with distilled water.
The slides were left to dry overnight, and coverslips were
mounted with either Vectashield (Vector Laboratories) or
Gel/Mount (Biomeda Corp, Foster City, CA).

J Neuropathol Exp Neurol  Volume 71, Number 3, March 2012
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FIGURE 1. Blood profile. (A) Isotype controls scatter plot. (B) F4/80-Ly6C/G scatter plot of blood showing the neutrophils (F4/
80-negative Ly6C/G-positive [blue box]) and the 2 monocyte populations (F4/80-positive Ly6C/G-positive [upper red box] and
F4/80-positive Ly6C/G-negative [lower red box]). (C) Histogram showing that the neutrophil and the 2 monocyte populations
are enhanced green fluorescent protein (EGFP) positive. (D) Digital fluorescent images of tomato lectin (TL, red) and anti-EGFP
(E, green) double-stained normal spinal cord demonstrating EGFP-positive cells in the pia (arrows) but not the cord parenchyma. (F) Digital fluorescent images of double stained section showing TL-positive ramified microglia that lack EGFP expression
(arrowheads point to microglia). (G) Digital fluorescent images of TL-positive, EGFP-positive perivascular cells associated with
larger blood vessels (arrows point to EGFP-positive cells). Data are representative of at least 3 independent experiments of 3 or
more mice. Scale bars = (D, E) 50 KM; (F, G) 10 Km.
Ó 2012 American Association of Neuropathologists, Inc.
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TABLE. Comparison of Leukocyte Subsets in Blood, Bone Marrow, and Spleen Between C57BL/6 and lys-EGFP-ki Mice
Blood
Classic monocytes
Gr-1hiF4/80+
Intermediate subset
Gr-1intF4/80+
Nonclassic monocytes
Gr-1loF4/80+
Lymphocytes CD3+CD19+
Neutrophils Gr-1hi
Ly6/GhiF4/80jSSChi

Bone Marrow

Spleen

C57BL/6

Lys-EGFP-ki

C57BL/6

Lys-EGFP-ki

C57BL/6

Lys-EGFP-ki

6.2% T 1.7%

7.8% T 1.5%

21.7% T 1.6%

20.1% T 0.9%

9.3% T 0.9%

11.5% T 0.5%

3.6% T 0.9%

8.1% T 1.5%

4.74% T 1.3%

5.74% T 1.3%

8.4% T 0.8%

11.1% T 1.8%

3.7% T 0.8%

4.1% T 0.3%

8.73% T 1.4%

7.43% T 1.5%

4.0% T 0.4%

4.3% T 0.6%

36.4% T 0.6%
21.9% T 2.2%

33.7% T 2.1%
26.3% T 1.3%

21.4% T 2.0%
38.8% T 4.2%

20.1% T 1.1%
42.4% T 4.6.%

88.5% T 1.4%
15.4% T 0.8%

82.5% T 5.6%
18.6% T 3.6%

suspension. The slides were rinsed with cold PBS 0.1% BSA
and ﬁltered through a 70-Km strainer. Percoll (Amersham
Biosciences, Uppsala, Sweden), made with pH 7.0 to 7.2 via
addition of 4-[2-hydroxyethyl]-1-piperazineethanesulfonic acid
(Invitrogen Corp, Carlsbad, CA) was added to the cell suspension to make a ﬁnal concentration of 30% vol/vol and centrifuged on a Percoll gradient to enrich for microglia/mM?
and hematogenous leukocytes (39). The banded cells were
removed from the gradient, washed, and labeled with antibodies as described previously for blood leukocytes.

Flow Cytometry
Blood and spinal cord cells were collected on a BD
Biosciences ﬂuorescence-activated cell sorting Calibur analog cytometer. Data acquisition was done using CELLQuest
software (version 10; BD Biosciences, Franklin Lakes, NJ). Analysis was performed on FlowJo software version 7.1.2 (Tree Star,
Inc, Ashland, OR). The viability of blood and spinal cord samples
was determined using the viability marker 7-aminoactinomycin D.

Statistics
Spinal Cord Preparation for Flow Cytometry
Transcardiac perfusions were performed with cold
Dulbecco modiﬁed Eagle medium after SCI. A total of 5 mm
of spinal cord was removed (2.5 mm rostral and caudal to the
lesion’s epicenter at spinal segment T5) from SCI mice (n = 4)
and ground between frosted slides into a homogenous cell

All experimental groups of mice contained 3 to 5 mice.
Data are expressed as mean T SEM. Graphic displays and
Student t test were performed using GraphPad Prism (version
4.0; GraphPad Software, La Jolla, CA). Two-way and oneway analyses of variance were done using GB Stat (version 7;
Dynamic Microsystems, Inc, Silver Spring, MD) or Sigma

FIGURE 2. Enhanced green fluorescent protein (EGFP) expression in spinal cord injured lys-EGFP-ki mice. (AYF) Hatched yellow
lines demarcate the outer edge of the spleen, spinal cord, and the gray matter and white matter interface. Fluorescent images of
uninjured lys-EGFP-ki (A) C57BL/6 (B) mice show EGFP expression only in the lys-EGFP-ki mouse spleen. Uninjured spinal cord
sections of lys-EGFP-ki (C) and C57BL/6 (D) mice lack significant EGFP (green) expression (pia removed from the spinal cord before
sectioning). Lys-EGFP-ki T4 spinal cord section at 3 days after SCI shows extensive EGFP expression (E) (open arrow head indicates
an EGFP-positive cell). No EGFP expression is observed in an equivalently injured C57BL/6 mouse T4 spinal cord section (F). (GYJ)
Alternate lys-EGFP-ki T4 spinal cord sections 3 days after SCI labeled with anti-Ly6/G (G), anti-F4/80 (H), and anti-CD11b (I)
antibodies. Digital confocal images were taken at the lesion site along with corresponding Z-stacked images (G¶, H¶, I¶, J¶) taken
every 1.5 Km and viewed perpendicularly. AntiYLy6/G-positive (red) stained EGFP-positive (green) neutrophil (G¶). Anti-F4/80
(red) stained EGFP-positive (green) hematogenous monocytes (hM?) (H¶). AntiYCD11b-positive (red) stained EGFP-positive
(green) monocyte-derived microglia (hM?) (I¶, arrow). An anti-CD11b (red) stained EGFP-negative ramified microglia cell (J¶).
(KYP) Spinal cord forward scatter (FSC) versus side scatter (SSC) profile (K, N) was gated to capture single viable cells and then
further analyzed with isotype control antibodies to establish positive gates (L, O) for F4/80-negative, Ly6/G-positive neutrophils
(M) and EGFP-negative, F4/80-positive macrophages derived from microglia (mM?) and EGFP-positive, F4/80-positive hM?
(P). Scale bars = (B, D) 200 Km and applies to A, C, E, and F; (G, H) 10 Km; (I, I¶, J, J¶) 5 Km.
Ó 2012 American Association of Neuropathologists, Inc.
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lysis buffer (Lonza Biowhittaker, Basel, Switzerland). Thereafter, the cells were washed with cold PBS 0.1% BSA and
then blocked with 5% (vol/vol) normal goat serum (Jackson
ImmunoResearch Laboratories, Inc), followed by a wash with
cold PBS 0.1% BSA. Primary antibodies, allophycocyaninconjugated anti-Ly6C/G (1:400; BD Biosciences, Mississauga,
Canada), phycoerythrin-conjugated anti-CD115 (1:100; eBioscience), Alexa Fluor 700Yconjugated anti-Ly6/G (1:100; BioLegends, San Diego, CA), and biotinylated anti-F4/80 (1:100;
AbD Serotec, Raleigh, NC) were added to 1  105 cells per 100 Kl
in individual ﬂow cytometry tubes (BD Biosciences). For all
staining procedures, isotype-matched control antibodies were
used. Samples were incubated for 30 minutes on ice in the dark,
washed with cold PBS 0.1% BSA, and centrifuged at 6-C. The
pelleted cells incubated with biotinylated antibody were
resuspended with streptavidin-phycoerythrin or streptavidinallophycocyanin in PBS 0.1% BSA (1:2000; BD Biosciences)
and incubated on ice for 30 minutes in the dark. Finally, cells
were washed and resuspended in 400 Kl of 0.5% paraformaldehyde ﬁxative.

J Neuropathol Exp Neurol  Volume 71, Number 3, March 2012
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Stat (version 3.0; Systat Software, Inc, San Jose, CA) followed by a Student-Newman-Keuls test for post hoc analysis.
For analysis, statistical signiﬁcance was accepted at p e 0.05.

RESULTS
Microglia Lack EGFP Expression in Normal
lys-EGFP-ki Mice

Microglia Lack EGFP Expression in SCI
lys-EGFP-ki Mice
We next examined EGFP expression in the injured spinal cord of lys-EGFP-ki mice. Very little EGFP-positive ﬂuorescence was observed in the uninjured spinal cord at T5,
and none was observed in a comparable region of spinal cord
from a wild-type C57BL/6 mouse (Figs. 2C, D). At 3 days
after injury at T5, green ﬂuorescence derived directly from
EGFP was present in the lesion (Fig. 2E), but not in the T5
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We examined the expression of EGFP in myeloid cells
of the blood and in the spinal cord of normal and SCI adult
homozygous lys-EGFP-ki mice. Flow cytometry of blood
samples demonstrated EGFP-positive, Ly6C/G-positive, F4/
80-negative neutrophils, and EGFP-positive expression in
the 2 major monocyte populations (EGFP-positive, Ly6C/Gpositive, F4/80low classic or proinﬂammatory monocytes and
the EGFP-positive, Ly6C/G-negative, F4/80high nonclassical
monocytes) (Figs. 1AYC). These are the 2 best-described
populations of monocytes known to circulate in the blood
of the mouse (35, 40, 41); these data conﬁrm that the mice
expressed the transgene in the correct population of leukocytes. In contrast, the uninjured spinal cord of the lys-EGFP-ki
mice was largely devoid of EGFP expression throughout the
gray and white matter (Figs. 1DYG). Enhanced green ﬂuorescent proteinYpositive monocyte/macrophages positive for
TL staining (Figs. 1D, E) as well as F4/80 (data not shown)
were observed throughout the pia that surrounds the spinal
cord. Tomato lectinYpositive microglia exhibiting a typical
ramiﬁed morphology were uniformly negative for EGFP expression (Figs. 1F, G). Occasionally, EGFP-positive leukocytes were observed in association with some, but not all,
blood vessels. Their spindle-shaped morphology suggested
they were likely perivascular macrophages (Fig. 1G) (42, 43).
Similar results were observed in normal lys-EGFP-ki brains
and in brains of lys-EGFP-ki mice subjected to LPS-induced
systemic inﬂammation (Figure, Supplemental Digital Content 1,
http://links.lww.com/NEN/A310). Taken together, these results
indicate that microglia in the normal and inﬂamed CNS do
not seem to express detectable levels of EGFP. However,
in normal Lys-EGFP-ki mice, but not in wild-type C57BL/6
mice, the spleen (Figs. 2A, B), as well as the bone marrow,
lungs, and liver, and lymph nodes (as determined by ﬂuorescence microscopy and/or ﬂow cytometry; data not shown)
all contained EGFP-positive cells of the myeloid lineage and/
or tissue macrophages. Flow cytometric analysis of the blood,
bone marrow, and spleen (independent of EGFP expression)
demonstrated no signiﬁcant differences in the percentage of
monocyte subsets, lymphocytes, and neutrophils between wildtype C57BL/6 mice and lys-EGFP-ki mice (Table).

lesion of a wild-type C57BL/6 mouse (Fig. 2F). To identify
the EGFP-positive cells, ﬁxed cryosections were immunostained (without detergent to avoid quenching EGFP-derived
ﬂuorescence) with antibodies to cell surface markers expressed
by neutrophils and microglia, mM? and hM?. Anti-Ly6/G is
a marker found predominantly on neutrophils (Figs. 2G, G¶).
The presence of side scatterhi (SSChi) Ly6C/G-positive, F4/
80-negative neutrophils in the 3-day injured spinal cord was
conﬁrmed by ﬂow cytometry (Figs. 2KYM). Subsequent backgating on the SSChi Ly6C/G-positive, F4/80-negative population demonstrated that they were EGFP positive (data not
shown). Enhanced green ﬂuorescent proteinYpositive, F4/80positive (Figs. 2H, H¶) and EGFP-positive, CD11b-positive
(Figs. 2I, I¶) hM? were detected in the lesion 3 days after
SCI by immunohistochemistry and at 7 days after SCI by ﬂow
cytometry (Figs. 2NYP). Enhanced green ﬂuorescent proteinY
negative, CD11b-positive mM? were detected by immunohistochemistry in the lesion 3 days after SCI (Figs. 2J, J¶), and
EGFP-negative, F4/80-positive mM? were detected by ﬂow
cytometry 7 days after SCI (Figs. 2NYP). These results support the hypothesis that microglia and mM? can be distinguished from hM? expressing EGFP in the lys-EGFP-ki
transgenic mouse SCI model.
To verify that microglia and mM? lack EGFP expression, we performed 2 additional experiments, one involving
reciprocal bone marrow transplantation between lys-EGFP-ki
and C57BL/6 mice and one involving depletion of hematogenous monocytes using clodronic acid liposomes (Fig. 3).
We transplanted bone marrow obtained from lys-EGFP-ki
mice into recipient C57BL/6 mice with the expectation that,
after SCI, the ensuing cellular inﬂammatory response would
look phenotypically similar to that seen in lys-EGFP-ki mice
because the only hematopoietic cells expressing EGFP would
be of donor origin, whereas microglia and mM? could not
express EGFP because they lack the transgene (Figs. 3A, B).
Using a reverse experimental design, bone marrow from
C57BL/6 mice was transplanted into lys-EGFP-ki mice. In
this situation, the only hematopoietic cells that could potentially express EGFP would be the microglia and mM? present
in the recipient lys-EGFP-ki mice because the circulating leukocytes would lack the EGFP transgene. Immediately, before
SCI, recipient blood samples were analyzed for EGFP expression. Less than 4% of the circulating blood leukocytes expressed
EGFP compared with normal lys-EGFP-ki mice (È27%). Enhanced green ﬂuorescent proteinYpositive, TL-positive cells
were almost completely absent from the lesion at 7 days after
injury (Fig. 3C). Quantiﬁcation of sections from these same
mice double stained for F4/80 and EGFP revealed extensive
F4/80 immunoreactivity and very little EGFP immunoreactivity throughout the lesion area (Fig. 3D).
Clodronate liposomes have been frequently used to deplete monocyte populations (3, 44Y46). Initially, we performed
a control experiment to demonstrate that clodronate liposomes
did not enter the SCI lesion. To do this, control liposomes containing only PBS were labeled with the membrane-intercalating
dye PKH26 (red) and injected i.v. (via the tail vein) and i.p.
either once, 1 day before SCI, or twice, 1 day before SCI and
at Day 3 after SCI. Neither at Day 1 nor at Day 4 after SCI
could PKH26-positive liposome material be detected in the T5
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spinal lesion, but it was readily detected in the spleen (Figure,
Supplemental Digital Content 2, http://links.lww.com/NEN/
A311). In addition, after clodronic acid liposome treatment,
ﬂow cytometry was performed for each treated animal on the
splenocytes and peripheral blood leukocytes to conﬁrm depletion of F4/80-positive blood monocytes. Only animals that
were determined to be depleted (having G10% of the normal
number of EGFP-positive leukocytes) were used in the study
(data not shown). We also determined that signiﬁcant numbers (910%Y15%) of EGFP-positive, F4/80-positive blood

monocytes did not reappear in the blood until 3 to 4 days after depletion, consistent with previous reports (47). Thus, we
treated SCI mice every fourth day with clodronic acid liposomes during a period of 14 days. This led to the successful depletion of EGFP-positive monocytes resulting in the
absence of EGFP-positive hM? in the injured spinal cord
(Fig. 3E). Thus, the BM transplant data and the monocyte
depletion data together indicate that the activation and differentiation of microglia into mM? does not lead to signiﬁcant EGFP expression.
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FIGURE 3. Reciprocal bone marrow (BM) transplantation and clodronic acid liposome depletion studies demonstrating a lack of
enhanced green fluorescent protein (EGFP) expression in microglia-derived macrophages (mM?) at 7 days after spinal cord injury
(SCI). (A, B) Digital fluorescence images show that the distribution of EGFP-positive (green) and tomato lectin (TL)Ypositive (red)
hematogenous monocytes (hM?) in the spinal lesion of a lys-EGFP-ki SCI mouse (A) is the same as in a wild-type C57BL/6 mouse
(B) transplanted with BM from lys-EGFP-ki mice (n = 4). (C) In the reciprocal situation, where lys-EGFP-ki mice were transplanted
with wild-type C57BL/6, BM EGFP-positive (green) TL-positive (red) monocyte-derived microglia (hM?) are absent from the lesion
(n = 4). (D) Alternate sections of the lesions of mice described in C were stained for EGFP and F4/80 (R is rostral, E is epicenter, C is
caudal). Quantitative analysis revealed that F4/80-positive cells are abundantly present and distributed throughout the lesion; EGFP
expression is absent. Significant differences between F4/80 and EGFP expression were assessed using a one-way analysis of variance
followed by a Student-Newman-Keuls post hoc test (p G 0.05) and indicated with asterisks. (E) A clodronic acid liposome-treated
SCI lys-EGFP-ki mouse also shows lack of EGFP expression in TL-positive mM? (n = 4). Scale bars = (E) 20 Km and applies to A to C.
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Expression and Distribution of EGFP-Positive
Neutrophils and hM? in the Injured Spinal Cord:
Days 1 and 3
A digital morphometric assessment was performed to
determine the distribution of EGFP-positive cells in the SCI
lesion. Because microglia and mM? lack EGFP expression,

such an assessment would not be confounded by phenotypic
markers that failed to discriminate between hematogenous
leukocytes and microglia and mM?. Enhanced green ﬂuorescent proteinYpositive neutrophils were identiﬁed by staining
with anti-Ly6/G antibody (an antibody that binds to neutrophils but not monocyte/M?) and by their resistance to clodronic

FIGURE 4. Quantification of Ly6/G and enhanced green fluorescent protein (EGFP) expression in control and clodronic acid
liposome-depleted animals at 1, 3, 7, and 14 days after spinal cord injury (SCI). The mean ratio of EGFP-positive area or Ly6/
G-positive area to area of interest (cross section of the spinal cord) is displayed in relation to the injured spinal cord section
on the x axis (R is rostral, E is epicenter, C is caudal). Variability is indicated by standard error bars for each group (n = 4). Significant
differences between the control and clodronic acid treated animals were assessed using a one-way analysis of variance followed by a
Student-Newman-Keuls post hoc test (p G 0.05) and indicated with asterisks.
Ó 2012 American Association of Neuropathologists, Inc.
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FIGURE 5. Distribution of neutrophils and macrophages in lys-EGFP-ki mice at 3 days after spinal cord injury (SCI). (AYF) Confocal
images of spinal cord lesion sections from Lys-EGFP-ki mice (n = 4) 3 days after SCI stained with anti-green fluorescent protein (GFP)
(green; A, D) and anti-Ly6/G (red; B, E) and then merged (C, F). Boxed areas in A to C are enlarged with nuclear 4’,6-diamidino2-phenylindole staining (blue) in D to F. (GYL) Confocal images of anti-GFP- (green; G, J) and anti-CD11b- (red; H, K) stained
spinal cord sections from an uninjured spinal cord (GYI) and at the lesion 3 days after SCI (JYL) followed by a merged image (I, L).
An example (JYL) of a CD11b-positive, EGFP-negative activated macrophage derived from microglia (mM?) is indicated by an
open arrowhead; a CD11b-positive, EGFP-positive hematogenous monocyte (hM?) is indicated by an arrow. EGFP-positive,
CD11b-negative neutrophils are indicated by closed arrowhead. Scale bars = (A) 100 Km applies to B and C; (D) 10 Km and
applies to E and F; (G) 50 Km and applies to H to L.
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acid liposome treatment, which allowed them to be distinguished from clodronic acid liposome treatment-sensitive EGFPpositive Ly6/G-monocyte/hM?. Flow cytometry performed on
the blood of each mouse at the time of death revealed that the
percentage of GFP-positive neutrophils (È60%Y70% of all
EGFP-positive blood leukocytes) did not vary substantially
during the 14-day time course of clodronate liposome treatment. All mice responded to the clodronate treatment.
At 8 hours after SCI, the inﬁltration of Ly6/G-positive
and EGFP-positive leukocytes was not signiﬁcant (data not
shown). The level of EGFP and Ly6/G expression increased
starting on Day 1 after SCI (Fig. 4). Similar levels of EGFP
and Ly6/G expression were also observed at Day 3 (Fig. 4).
The EGFP expression was greatest at the lesion’s epicenter
(E) and decreased steadily in the rostral (R) and caudal (C)
sections examined. At both time points, most of the EGFPpositive and Ly6/G-positive cells were resistant to the clodronate liposome treatment, suggesting that they were likely

neutrophils. This result was further conﬁrmed by staining sections for MPO, a known marker of neutrophils (34, 48). The
distribution of MPO-positive neutrophils from lys-EGFP-ki
mice across the spinal lesion was similar to the distribution of
Ly6/G-positive cells at Day 3 after SCI and was not substantially different from the distribution of MPO-positive cells
observed across the lesion of wild-type C57BL/6 mice at
Day 3 after SCI (Figure, Supplemental Digital Content 3,
http://links.lww.com/NEN/A312). Furthermore, at 1 and 3 days
after SCI, spinal cord lesion homogenates from lys-EGFP-ki
SCI mice (n = 4Y5) were assayed for MPO enzymatic activity
and to detect MDA, a product of lipid peroxidation. In lysEGFP-ki mice after SCI, the MPO activity (Day 1, 34 T 13 U/g
tissue; Day 3, 31 T 9.4 U/g tissue) and MDA (Day 1, 581 T
32 nmol/L per gram of tissue: Day 3, 457 T 85) assay results
were similar to the values in C57BL/6 mice after SCI for
MPO activity (Day 1, 45 T 3 U/g tissue; Day 3, 28 T 6.4 U/g
tissue) and MDA (Day 1, 474 T 37 nmol/L per gram of tissue;

FIGURE 6. Distribution of macrophages in mice at 7 and 14 days after spinal cord injury (SCI) reveals clusters of centrally located
enhanced green fluorescent protein (EGFP)Ypositive hematogenous macrophages (hM?) surrounded by EGFP-negative microglia
and macrophages derived from microglia (mM?). (AYE) Lys-EGFP-ki spinal cord sections from mice 7 days after SCI at (A, B) and
caudal (160Y320 Km from the epicenter; C, D) to the lesion double stained with anti-GFP (green; A, C) and anti-F4/80 (red; B, D).
The yellow box in C encloses the area shown with a higher magnification in E, a merge of EGFP (green), F4/80 (red), and 4’,6diamidino-2-phenylindole (blue, for nuclei) staining. Arrow indicates an EGFP-positive, F4/80-positive rounded hM?; the arrowhead indicates an EGFP-negative, F4/80-positive ramified mM?. FYJ: lys-EGFP-ki spinal cord sections from mice 14 days after SCI at
(F, G) and caudal (160Y320 Km from the epicenter; H, I) to the lesion double stained with anti-GFP (green; F, H) and anti-F4/80
(red; G, I). The yellow box in H encloses the area shown with a higher magnification in J, a merge of EGFP (green), F4/80 (red), and
4’,6-diamidino-2-phenylindole (blue, for nuclei) staining. Arrow indicates an EGFP-positive, F4/80-positive rounded hM?; the
arrowhead indicates an EGFP-negative, F4/80-positive ramified mM?. Scale bars = (A) 50 Km and applies to B to D and F to I; (E)
20 Km.
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FIGURE 7. Clusters of enhanced green fluorescent protein (EGFP)Ynegative, F4/80-positive microglia macrophages (mM?) extend
beyond the presence of EGFP-positive hematogenous macrophages (hM?) in untreated lys-EGFP-ki mice at 14 days after spinal
cord injury (SCI). Spinal cord sections (dorsal side of cord is at the top of each image) from SCI mice were double stained with antiGFP (A, green) and F4/80 (B, red) antibodies. The numbers below panel (B) indicate the distance (in Km) each section is from the
section shown in the epicenter of the lesion in the caudal [C] direction. The distributions of EGFP-positive and F4/80-positive cells
were examined at the epicenter and in sections caudal to the lesion site at 160-Km intervals. Clustered EGFP-negative, F4/80positive microglia extend beyond the point at which EGFP-positive, F4/80-positive hM? can last be observed at 640 Km caudal to
the lesion. Scale bars = 300 Km.
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Expression and Distribution of EGFP-Positive
Neutrophils and hM? in the Injured Spinal Cord:
Days 7 and 14
At 7 and 14 days after SCI, EGFP expression differed
signiﬁcantly between the untreated control and clodronic acid
liposomeYdepleted groups (Fig. 4). The expression of EGFP
in the SCI lesion’s epicenter in the untreated control group
increased from Day 3 after SCI values by È8-fold at Day 7
and 14-fold at Day 14. These ﬁndings contrasted with the
clodronic acid liposome-treated groups in the Days 7 and 14
groups, where EGFP expression decreased almost 36- and
15-fold, respectively, compared with their corresponding untreated groups. On Day 14 after SCI, Ly6/G-positive cells reappeared at the lesion’s epicenter (Fig. 4; 14 days) and in the
closest adjacent rostral and caudal section. This reappearance
of Ly6/G-positive cells, likely neutrophils, seems to depend
on the presence of hM? as Ly6/G expression did not increase
in the lesions epicenters of clodronic acid liposomeYtreated
SCI mice.
The distribution of lesion-associated hM? and microglia/
mM? was characterized at Days 7 and 14 after SCI. Macrophages derived from hematogenous monocytes or microglia
were identiﬁed by staining with the antibody to the macrophage marker F4/80. At Day 7 (Figs. 6AYE) and Day 14
(Figs. 6FYJ), F4/80-positive cells were present. However,
rather than being diffusely distributed throughout the lesion,
as observed at Days 1 and 3 after SCI, the F4/80-positive macrophages had coalesced more densely. Both individual and

clustered EGFP-positive, F480-positive hM? seemed to be
surrounded and mixed in with EGFP-negative, F4/80-positive
mM? (Figs. 6A, B, F, G) at the epicenter, as well caudal
(Figs. 6C, D, H, I) and rostral (data not shown) to the epicenter. The morphology of the F4/80-positive, EGFP-positive
cells observed at both time points was typical of rounded
hM? (Figs. 6E, J, arrow). The EGFP-negative, F4/80-positive
microglia/mM? exhibited either a stellate- or a stubby-activated
morphology, particularly near the peripheral edges where
macrophages had coalesced or had typical rounded macrophage morphology (Figs. 6E, J, arrowhead). The F4/80positive, EGFP-positive cells present at Days 7 and 14 after
SCI seemed to be concentrated in the regions that normally
contain gray matter. In clodronic acid liposomeYtreated animals, whereas EGFP expression was largely absent (Figure,
Supplemental Digital Content 4, parts A, C, E, F,
http://links.lww.com/NEN/A314), a condensed but evenly
distributed EGFP-negative, F4/80-positive population was still
present in the lesion at Days 7 and 14 after SCI, equivalent to
that seen in animals that had not been treated with clodronate
liposomes.
Examination of the distribution of EGFP-positive and
F480-positive cells along the length of the lesion revealed a
further difference in the distribution of hM? and mM?. As
shown in Figures 7A and B, clusters of EGFP-negative, F4/
80-positive cells persisted for at least 200 to 300 Km beyond
the point where EGFP-positive cells could be observed. This
was true in the rostral direction as well (data not shown).
Thus, the extent of the microglial-based inﬂammatory response
throughout the lesion did not seem to depend on the presence of
inﬁltrating hM?. The extent of the spinal lesion (800Y1000 Km
in length), as assessed by solochrome cyanin staining for myelin
was not different from the extent we reported for C57BL/6 mice
after clip compression SCI (50).

EGFP Expression in the Injured Spinal Cord
at Day 42
At 42 days after injury, we examined sections of injured
spinal cord for the presence of neutrophils using the anti-Ly6/
G antibody. Enhanced green ﬂuorescent proteinYpositive, Ly6/
G-positive cells were still present but were predominantly
restricted to a very narrow region surrounding the epicenter
(160 Km on either side; Fig. 8A). At the epicenter, EGFPpositive, Ly6/G-positive cells were distributed throughout but
were also interspersed within large clusters of EGFP-positive
cells (Figs. 8A, C). Most of the EGFP-positive cells in such
clusters were likely hM? because an adjacent section stained
for TL and EGFP revealed that most cells in the clusters

FIGURE 8. Distribution of anti-Ly6/G and biotinylated tomato lectin (TL) binding and enhanced green fluorescent protein (EGFP)
expression in the lys-EGFP-ki mice at 42 days after spinal cord injury (SCI). (A, B) Spinal cord sections (dorsal side of cord is at the
top of each image) from SCI mice 42 days after injury double stained with either (A) anti-Ly6/G and anti-EGFP or with (B) TL and
anti-EGFP reveal the chronic persistence of neutrophils in the lesion area and in clusters of macrophages. The numbers below
each panel in A and B indicate the distance (Km) each section is from the section shown in the epicenter of the lesion in the
rostral [R] and caudal [C] direction. Arrowhead in R640 of A indicates an example of a Ly6/G-positive, GFP-positive neutrophil in
the pia. Arrows in R640 A correspond to the arrows in the inset and indicate the location of rare EGFP-positive, Ly6/G-positive
cells located in the parenchyma away from the lesion’s epicenter. (C, D) Magnified merged images of the 2 boxed areas in the
epicenter A and B. Scale bars = (A, B) 100 Km; (C, D) 50 Km. Scale bar in R640 panels of A = 10 Km.
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Day 3, 500 T 34 nmol/L per gram of tissue). These ﬁndings indicate that some of the downstream effects of neutrophil and
monocyte inﬁltration within the lesion of lys-EGFP-ki mice
are not different from those in wild-type C57BL/6 mice.
The spatial distributions of Ly6/G-positive, EGFPpositive and Ly6/G-negative, EGFP-positive cells in the lesion at Days 1 and 3 after SCI were similar, with both cell
populations dispersed across the lesion (Figs. 5AYC) and no
real concentration in the gray or white matter. To look more
speciﬁcally at hM? and microglia/mM?, alternate sections
were stained with anti-CD11b because neutrophils rapidly lose
CD11b expression after extravasation across the endothelium
(49). Like Ly6/G-positive neutrophils, the CD11b-positive,
EGFP-positive cells (Figs. 5JYL, arrow) were dispersed throughout the lesion but were more prominent in the gray matter and
were surrounded by CD11b-positive, EGFP-negative activated microglia/mM? (Figs. 5JYL, open arrowhead). Smaller
CD11b-EGFP-positive cells, likely neutrophils, were also present (Figs. 5JYL, closed arrowhead).

Macrophage Response to Spinal Cord Injury in Mice
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DISCUSSION
The lys-EGFP-ki transgenic mouse model allows
EGFP to mark mature hematogenous granulomyelocytic
cells including neutrophils, monocytes, and hM? (28). The
EGFP gene was knocked into the lysozyme M locus resulting in expression driven by the lysozyme M promoter in its
native context. Therefore, EGFP expression faithfully identiﬁes the cells that normally express lysozyme M in the
absence of any other genetic or immunologic modiﬁcation of
the mouse. This idea has now been used by others to
examine the role of neutrophils and monocyte/macrophages
in a model of atherosclerosis (27). The data presented in this
study support our contention that EGFP expression in the lysEGFP-ki mouse permits the distinction of microglia/mM?
from neutrophils and monocyte/hM?. Our study shows that
this transgenic mouse is a convenient and valuable tool for
examining the distinct roles of microglia/mM?, neutrophils,
and monocyte/hM? in the injured spinal cord. The control of
the lysozyme M promoter in the myeloid lineage cells in
peripheral circulation and tissues is likely different from that
of CNS microglia because they are ontologically distinct cell
lineages (51). In uninjured CNS parenchyma, resting microglia of the brain and spinal cord do not express EGFP in the
spinal cord or in the brain. This observation parallels the
absence of EGFP expression in lys-EGFP-ki microglia/mM?
in other mouse models of CNS pathology, such as experimental autoimmune encephalomyelitis (30), and in the brains
of lys-EGFP-ki mice injected systemically with toxic LPS.
Consistent with the known pattern of lysozyme M expression
in various mouse tissues (27, 53), uninjured lys-EGFP-ki mice
express EGFP in their circulating leukocytes of the myeloid
lineage and in tissue macrophages from spleen, as well as the
lung and liver (J. Cheung and G. A. Dekaban, unpublished
results). In tissues bordering the CNS (e.g. within blood vessel walls), spindle-shaped EGFP-positive, hM? with mor-
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phology typical of perivascular M? have been observed (43,
54, 55). As expected, we observed EGFP-positive hM?
within the meninges because these cells regularly interchange
with circulating monocytes (54Y56). Although not exhaustively
assessed, we did not see any substantial differences between
lys-EGFP-ki and wild-type C57BL/6 mice in their leukocyte
populations and in their leukocyte responses to SCI. Thus,
the lys-EGFP-ki transgenic mouse offers an alternative model
to allow hM? and mM? to be distinguished easily without
injuring the animal or perturbing the immune system of the
animal before SCI.
Experimental approaches to distinguishing microglia
and mM? from monocytes and hM? include selectively depletion of hematogenous monocytes and hM? with the aim of
examining only the microglial and mM? response (3). However, in the absence of hM?, the spatial, temporal, and functional nature of the microglial-based response may be altered.
Bone marrow chimeras derived by transplantation of donor
cells expressing either a different MHC haplotype or expressing GFP also have been used to identify aspects of the temporal and spatial distribution of hM? and mM? (16, 18).
However, the generation of bone marrow chimera requires
that the recipients be lethally irradiated, resulting in injury to
the recipient that includes the CNS. Such irradiation-induced
CNS injury can result in the arrival of donor bone marrow
progenitors into the spinal cord and replacement of endogenous microglia with donor-derived cells that differentiate into
microglia of the donor genetic background (24). The degree
of chimerism is seldom described nor is the uniformity of
chimerism ensured within a group of animals under study.
Thus, interpretation of data from analyses of bone marrow
chimeras may not always be clear. Shielding the head during
radiation or minimizing the dose of radiation needed seems
to minimize but may not eliminate this problem (18, 57).
To verify further that microglia and mM? did not
convert to an EGFP-positive phenotype after SCI, bone marrow transplantation and hematogenous monocyte depletion
were carried out. In neither case did microglia become EGFP
positive. In the clodronic acid liposome depletion experiments,
we injected the liposomes only into the blood and peritoneal
cavity to produce an optimal depletion of systemic monocytes
and hM?. Clodronic acid liposomes administered in this
manner do not deplete EGFP-positive neutrophils, perivascular, or meningeal M? or EGFP- microglia or mM? (58Y60).
We did not inject the clodronate liposomes into the fourth ventricle, a method known to deplete meningeal and perivascular M? (58) because this could have led to depletion of
activated microglia and mM? in the presence of the SCI.
Thus, the EGFP-positive meningeal and perivascular hM?
both can migrate to sites of CNS inﬂammation (43, 54, 55) and
may have contributed to few the EGFP-positive cells present
in the lesion’s epicenter and surrounding areas. Because the
number of meningeal or perivascular EGFP-positive hM? in
the injured spinal cord was small, these hM? would have
contributed only a minor portion of the EGFP-positive hM?
found at the lesion.
On the basis of the quantitative immunohistochemical
and ﬂow cytometry analysis, the temporal appearance and
spatial distribution of microglia/mM?, neutrophils, and hM?
Ó 2012 American Association of Neuropathologists, Inc.
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stained positive for both (Fig. 8D). Examination of sections
more rostral (Fig. 8A; R640) or caudal (data not shown) to the
epicenter revealed very few neutrophils that, when present,
were generally located in the pia and occasionally in the parenchyma (Fig. 8A, arrows, R640 panel).
At Day 42 after SCI, EGFP-positive, TL-positive (Fig. 8B)
and F4/80-positive (data not shown) hM? were still present,
although the extent of the cellular inﬂammatory response was
considerably diminished. Moving rostrally or caudally away
from the lesion’s epicenter, small clusters of EGFP-positive, TLpositive cells, as well as a scattering of individual cells, remained evident (Fig. 8B, R160 Km to R480 Km). At 480 Km
rostral to the lesion’s epicenter, individual EGFP-positive
cells were still evident in cord sections with a relatively normal gray and white matter distribution. In the caudal direction
similar, although somewhat larger, clusters and individual
groupings of cells were evident in sections immediately adjacent to the epicenter. As on the rostral side, by 480 Km caudal to the lesion, only scattered EGFP-positive, TL-positive
cells were evident. This distribution of macrophages contrasts
with the broader distribution observed at 14 days after SCI
(Fig. 7).
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because clodronic acid liposome depletion of hM? prevented
the reappearance of Ly6/G-positive neutrophils from appearing at Day 14, our data indicate that the reappearance of the
Ly6/G-positive neutrophils at Day 14 (and likely beyond) may
depend on the presence of hM?. The arriving hM? likely produce a second wave of cytokines (e.g. tumor necrosis factor
and macrophage-derived neutrophil chemotactic factor) and
chemokines that recruit additional neutrophils to the lesion’s
epicenter and/or extend the life of neutrophils beyond their
typical short life span (64). Further investigation is required
to understand the exact mechanism behind the reappearance
of the Ly6/G-positive cells. The persistence of neutrophils in
mice may contribute to the establishment of a chronic inﬂammatory state in the SCI lesion area. It is becoming increasingly
evident that neutrophils may have more complex role to play
in inﬂammation with possible participation in antigen presentation, autoimmunity, and regulation of T-cell responses (65),
but the signiﬁcance of this observation needs to be considered
carefully because a prolonged neutrophil presence has not
been observed in other species including humans (33, 66).
Marker expression of EGFP under the control of the
lysozyme M promoter should be a useful tool in the presence
of microglia and mM? to determine whether the various monocyte subsets that exist in the blood have similar counterparts
as hM? in SCI lesions. Within the blood, at least 2 monocyte
subsets (i.e. classic or proinﬂammatory monocytes [Ly6C/
G-negative, F4/80low] and the nonclassic subset [Ly6C/
G-negative F4/80hi]) are easily identiﬁed; the latter are thought
to be the pool of monocytes that maintain populations of tissue macrophage and have a role in tissue homeostasis (35, 40).
Others have deﬁned monocyte/macrophages on a more functional basis, such as the M1 and M2 classiﬁcation, which consists of at least 3 possible M2 subsets (67Y69). The M1 and M2
classiﬁcation seems to relate to the classic and nonclassic definition of monocyte subsets, respectively. M1 and M2 macrophages both exist in the lesion of SCI mice with the presence
of M1 macrophages associated with neuronal toxicity (23, 68,
69), although the absolute nature of this conclusion remains
in question (18, 57). Using the lys-EGFP-ki mouse, it will
be possible to distinguish M1 and M2 hM? from mM?,
thereby permitting a more accurate assessment of the phenotype and function of these 2 populations. Our study also suggests that the lysozyme M Cre conditional knockout mouse
could be very useful in differentially knocking out genes in
neutrophils, monocytes, and/or hM? whereas not affecting microglia and mM? (70, 71). Furthermore, preclinical studies
involving therapies to reduce the inﬂammatory response mediated by hematogenous neutrophils and monocyte/hM? will
be able to assess the effects of therapy on these EGFP-positive
myeloid cells without being confounded by the presence of
microglia/mM?. Such studies may further deﬁne the role of
microglia/mM? and hM? in SCI and lead to improved and
more targeted therapies to enhance neuroprotection and neuroregeneration of the injured spinal cord.
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conﬁrm previous data of others using rat and mouse models
(1, 16, 56, 60Y63). The data also closely parallel the observations obtained from an analysis of human SCI (32). Neutrophils in mice appear in maximal numbers at 3 days after
SCI, as shown here and by others (52). This is more similar
to human SCI in which we reported peak numbers at Days 3
to 5 after injury (32) as opposed to the rat where peak numbers of neutrophils appear much earlier at 8 hours (34). All 3
species have a similar macrophage response that peaks at
7 days after SCI (33, 52). These similarities validate the present model for study of the cellular inﬂammatory response to
SCI. The similarity of our results with the data gathered using
bone marrow transplantation after full body irradiation suggests that radiation-induced CNS injury in mice and rats does
not signiﬁcantly affect the nature of the ensuing inﬂammatory
response after SCI. Furthermore, the data also demonstrate
that the cellular inﬂammatory response in the clip compression injury used in this study is similar to that in contusion
injury models used by others (1, 16, 52). Thus, ischemic injury, at least within the time frame of our study, did not induce
substantial qualitative differences in the inﬂammatory response
when compared to the contusion injury. This conclusion should
be veriﬁed directly by a study of contusion SCI in the lysEGFP-ki mouse.
Despite the similarities in our data to those of others,
there were additional notable ﬁndings. Unlike depletion studies in the rat, where macrophages were absent in the central
gray matter of the lesion, we found that the mM? were distributed throughout the lesion area. Furthermore, in mice that
are not depleted, EGFP-positive hM? seem to be centrally
located and to dominate the macrophage clusters in the lesion;
these EGFP-positive hM? are interspersed with mM? in areas
normally containing gray matter. The EGFP-positive hM?
are surrounded by large numbers of activated stellate microglia and mM?. Although this is similar to some reports in mice
and rats (16, 52), our data contrast with the observations of
Schecter et al (18) in which hM? were described as conﬁned
to the edges of the lesion without entering it. Our data clearly
support the concept that hM? inﬁltrate the center of the lesion and are available to clear cellular debris and participate
in other wound healing activities.
The clusters of EGFP-mM? that extended beyond the
presence of EGFP-positive hM? at 14 days after SCI has not
been previously demonstrated in mice; this ﬁnding is consistent with data obtained in SCI rats (16). By 42 days after SCI,
both the hM? and the microglial and mM? distribution had
shortened signiﬁcantly, and they were concentrated predominantly near the lesion’s epicenter. At this chronic time point,
the remaining macrophage inﬂammatory response was focused
in smaller clusters of hM? interspersed with Ly6/G-positive
neutrophils surrounded by a less extensive layer of mM? and
microglia.
Finally, our data conﬁrm that Ly6/G-positive neutrophils in mice have a peak response at 3 days after SCI but do
not completely disappear thereafter. Rather, Ly6/G-positive
neutrophils continue to persist at the lesion’s epicenter and
regions immediately adjacent to the epicenter for at least
6 weeks. This is consistent with the ﬁndings of others, as well
as our recent ﬁndings in C57BL/6 mice (50, 52). Importantly,
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